Investigational^↗Metabolic^↗

Petrelintide^↗

Related names in cited records: ZP8396^↗

An amylin analogue candidate. This profile cites a ClinicalTrials.gov study record that was not yet recruiting.^↗

Citation markers ↗ open the public records supporting the adjacent statements.

Profile update · July 27, 2026

We rewrote the profile summary to describe the cited study record more directly. The cited source and status did not change. ¹

This version supersedes public version 1.

Evidence summary

What the cited records say

ClinicalTrials.gov lists a Roche-sponsored combination study as not yet recruiting, updated July 7, 2026.^↗

This is a source summary, not a medical recommendation. Status may differ by jurisdiction and product.

Cited context

Dated source history

July 7, 2026
Clinical trials
Petrelintide combination study record posted^↗
ClinicalTrials.gov lists a Petrelintide study that is not yet recruiting sponsored by Hoffmann-La Roche.^↗